The drugs included in BALANCE: Both Novo Nordisk and Eli Lilly have agreed to participate in the model, and the following medications will be included: all formulations of Mounjaro, Ozempic, Rybelsus, and Wegovy, the KwikPen formulation of Zepbound, and, if approved by the FDA, the tablet formulation of Orforglipron
Foundayo, containing orforglipron as a novel oral GLP-1, can be ingested anytime without food or water restrictions, offering optimal convenience
Pancreatitis has been associated with GLP-1 medication use as well, though it is not among the more common side effects
Having a BMI of 27 or above while also having a coinciding weight-related medical condition
It is important to note that the direction and magnitude of the relationship between cannabinoids and insulin is not linear, and may depend on multiple factors such as baseline metabolic state, duration and frequency of exposure, etc
Grill HJ, Hayes MR